• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶菌噬菌体诱导的结构变化使环丙沙星对肺炎克雷伯氏菌的旧生物膜有效。

Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae.

机构信息

Department of Microbiology, Basic Medical Sciences (BMS) Block, Panjab University, Chandigarh, India.

出版信息

Biofouling. 2010 Aug;26(6):729-37. doi: 10.1080/08927014.2010.511196.

DOI:10.1080/08927014.2010.511196
PMID:20711894
Abstract

Bacteria have evolved multiple mechanisms, such as biofilm formation, to thwart antibiotic action. Yet antibiotics remain the drug of choice against clinical infections. It has been documented that young biofilm of Klebsiella pneumoniae could be eradicated significantly by ciprofloxacin treatment alone. Since age of biofilm is a decisive factor in determining the outcome of antibiotic treatment, in the present study biofilm of K. pneumoniae, grown for extended periods was treated with ciprofloxacin and/or depolymerase producing lytic bacteriophage (KPO1K2). The reduction in bacterial numbers of older biofilm was greater after application of the two agents in combination as ciprofloxacin alone could not reduce bacterial biomass significantly in older biofilms (P > 0.05). Confocal microscopy suggested the induction of structural changes in the biofilm matrix and a decrease in micro-colony size after KPO1K2 treatment. The role of phage associated depolymerase was emphasized by the insignificant eradication of biofilm by a non-depolymerase producing bacteriophage that, however, eradicated the biofilm when applied concomitantly with purified depolymerase. These findings demonstrate that a lytic bacteriophage alone can eradicate older biofilms significantly and its action is primarily depolymerase mediated. However, application of phage and antibiotic in combination resulted in slightly increased biofilm eradication confirming the speculation that antibiotic efficacy can be augmented by bacteriophage.

摘要

细菌已经进化出多种机制,如生物膜形成,以抵御抗生素的作用。然而,抗生素仍然是治疗临床感染的首选药物。有文献记载,单纯用环丙沙星治疗可以显著清除肺炎克雷伯菌的年轻生物膜。由于生物膜的年龄是决定抗生素治疗效果的决定性因素,在本研究中,用环丙沙星和/或产解聚酶的裂解噬菌体(KPO1K2)处理长时间生长的肺炎克雷伯菌生物膜。两种药物联合应用后,老年生物膜中细菌数量的减少更为显著,因为单独使用环丙沙星不能显著减少老年生物膜中的细菌生物量(P>0.05)。共聚焦显微镜提示 KPO1K2 处理后生物膜基质结构发生变化,微菌落大小减小。非产解聚酶噬菌体对生物膜的清除作用不显著,而当与纯化的解聚酶同时应用时,却能清除生物膜,这强调了噬菌体相关解聚酶的作用。这些发现表明,单独使用裂解噬菌体可以显著清除老年生物膜,其作用主要是通过解聚酶介导的。然而,噬菌体和抗生素联合应用可略微增加生物膜的清除率,证实了抗生素疗效可以通过噬菌体增强的推测。

相似文献

1
Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae.溶菌噬菌体诱导的结构变化使环丙沙星对肺炎克雷伯氏菌的旧生物膜有效。
Biofouling. 2010 Aug;26(6):729-37. doi: 10.1080/08927014.2010.511196.
2
Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment.通过互补噬菌体治疗限制肺炎克雷伯菌 B5055 生物膜中环丙沙星诱导的耐药变异体形成。
J Antimicrob Chemother. 2009 Dec;64(6):1212-8. doi: 10.1093/jac/dkp360. Epub 2009 Oct 4.
3
In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.抗生素封管技术(ALT)对铜绿假单胞菌和肺炎克雷伯菌所致导管相关感染的体外治疗效果。
J Antimicrob Chemother. 2007 Oct;60(4):782-7. doi: 10.1093/jac/dkm295. Epub 2007 Aug 5.
4
Susceptibility of different phases of biofilm of Klebsiella pneumoniae to three different antibiotics.肺炎克雷伯菌不同生长阶段生物膜对三种不同抗生素的敏感性。
J Antibiot (Tokyo). 2013 Feb;66(2):61-6. doi: 10.1038/ja.2012.101. Epub 2012 Nov 21.
5
Advantages and limitations of microtiter biofilm assays in the model of antibiofilm activity of Klebsiella phage KP34 and its depolymerase.微载体生物膜测定法在噬菌体 KP34 及其解聚酶抗生物膜活性模型中的优势和局限性。
Sci Rep. 2020 Nov 23;10(1):20338. doi: 10.1038/s41598-020-77198-5.
6
Combination of essential oil and ciprofloxacin to inhibit/eradicate biofilms in multidrug-resistant Klebsiella pneumoniae.精油与环丙沙星联合抑制/清除多重耐药肺炎克雷伯菌生物膜。
J Appl Microbiol. 2018 Jul;125(1):84-95. doi: 10.1111/jam.13755. Epub 2018 Apr 19.
7
Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin.点状气单胞菌衍生的解聚酶提高了肺炎克雷伯菌生物膜对庆大霉素的敏感性。
BMC Microbiol. 2015 Jun 11;15:119. doi: 10.1186/s12866-015-0455-z.
8
Disrupting the mixed-species biofilm of Klebsiella pneumoniae B5055 and Pseudomonas aeruginosa PAO using bacteriophages alone or in combination with xylitol.单独使用噬菌体或与木糖醇联合使用破坏肺炎克雷伯菌B5055和铜绿假单胞菌PAO的混合物种生物膜。
Microbiology (Reading). 2015 Jul;161(7):1369-77. doi: 10.1099/mic.0.000104. Epub 2015 Apr 28.
9
Inhibiting biofilm formation by Klebsiella pneumoniae B5055 using an iron antagonizing molecule and a bacteriophage.利用一种铁拮抗分子和噬菌体抑制肺炎克雷伯氏菌 B5055 生物膜的形成。
BMC Microbiol. 2013 Jul 26;13:174. doi: 10.1186/1471-2180-13-174.
10
Artificial Klebsiella pneumoniae biofilm model mimicking in vivo system: altered morphological characteristics and antibiotic resistance.人工肺炎克雷伯氏菌生物膜模型模拟体内系统:形态特征改变和抗生素耐药性。
J Antibiot (Tokyo). 2014 Apr;67(4):305-9. doi: 10.1038/ja.2013.139. Epub 2014 Jan 15.

引用本文的文献

1
Isolation and identification of bacteriophage against Escherichia coli ATCC 25922 and their biofilm Inhibition studies.抗大肠杆菌ATCC 25922噬菌体的分离鉴定及其生物膜抑制研究。
Sci Rep. 2025 Jul 24;15(1):26964. doi: 10.1038/s41598-025-12366-z.
2
Combined Forces Against Bacteria: Phages and Antibiotics.对抗细菌的联合力量:噬菌体与抗生素
Health Sci Rep. 2025 Jul 9;8(7):e70956. doi: 10.1002/hsr2.70956. eCollection 2025 Jul.
3
Comprehensive genomic and evolutionary analysis of biofilm matrix clusters and proteins in the genus.
该属生物膜基质簇和蛋白质的综合基因组与进化分析。
mSystems. 2025 May 20;10(5):e0006025. doi: 10.1128/msystems.00060-25. Epub 2025 Apr 10.
4
Phage-antibiotic combinations against : impact of methodological approaches on effect evaluation.噬菌体-抗生素联合疗法:方法学途径对疗效评估的影响
Front Microbiol. 2025 Mar 12;16:1530819. doi: 10.3389/fmicb.2025.1530819. eCollection 2025.
5
Bacteriophage-derived depolymerase: a review on prospective antibacterial agents to combat Klebsiella pneumoniae.噬菌体衍生的解聚酶:对抗肺炎克雷伯菌的潜在抗菌剂综述
Arch Virol. 2025 Mar 8;170(4):70. doi: 10.1007/s00705-025-06257-x.
6
Enhanced bacteriostatic effects of phage vB_C4 and cell wall-targeting antibiotic combinations against drug-resistant .噬菌体vB_C4与细胞壁靶向抗生素联合使用对耐药菌的抑菌作用增强。
Microbiol Spectr. 2025 Feb 4;13(2):e0190824. doi: 10.1128/spectrum.01908-24. Epub 2025 Jan 16.
7
Specificity and diversity of Klebsiella pneumoniae phage-encoded capsule depolymerases.肺炎克雷伯菌噬菌体编码的荚膜解聚酶的特异性和多样性。
Essays Biochem. 2024 Dec 17;68(5):661-677. doi: 10.1042/EBC20240015.
8
Comprehensive Genomic and Evolutionary Analysis of Biofilm Matrix Clusters and Proteins in the Genus.该属生物膜基质簇和蛋白质的综合基因组与进化分析
bioRxiv. 2025 Jan 14:2024.08.19.608685. doi: 10.1101/2024.08.19.608685.
9
The potential use of bacteriophages as antibacterial agents against Klebsiella pneumoniae.噬菌体作为抗肺炎克雷伯菌抗菌剂的潜在用途。
Virol J. 2024 Aug 19;21(1):191. doi: 10.1186/s12985-024-02450-7.
10
Characterization of bacteriophages and control hemorrhagic pneumonia on a mice model.噬菌体的特性鉴定及小鼠模型上出血性肺炎的控制
Front Microbiol. 2024 May 14;15:1396774. doi: 10.3389/fmicb.2024.1396774. eCollection 2024.